Suivre
Torbjørn Wisløff
Torbjørn Wisløff
Akershus University Hospital, Norway
Adresse e-mail validée de fhi.no
Titre
Citée par
Citée par
Année
Urban air pollution and mortality in a cohort of Norwegian men.
P Nafstad, LL Håheim, T Wisløff, F Gram, B Oftedal, I Holme, I Hjermann, ...
Environmental health perspectives 112 (5), 610-615, 2004
3652004
Cancer risk with folic acid supplements: a systematic review and meta-analysis
TN Wien, E Pike, T Wisløff, A Staff, S Smeland, M Klemp
BMJ open 2 (1), e000653, 2012
2402012
Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: a population-based study using comprehensive health and welfare registers
S Evensen, T Wisløff, JU Lystad, H Bull, T Ueland, E Falkum
Schizophrenia bulletin 42 (2), 476-483, 2016
2352016
Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years
L Lund Håheim, TF Wisløff, I Holme, P Nafstad
American journal of epidemiology 164 (8), 769-774, 2006
1962006
Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010
T Wisløff, G Hagen, V Hamidi, E Movik, M Klemp, JA Olsen
Pharmacoeconomics 32, 367-375, 2014
1912014
Transparent development of the WHO rapid advice guidelines
HJ Schünemann, SR Hill, M Kakad, GE Vist, R Bellamy, L Stockman, ...
PLoS medicine 4 (5), e119, 2007
1702007
Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program
T Wisløff, TG Abrahamsen, MAR Bergsaker, Ø Løvoll, P Møller, ...
Vaccine 24 (29-30), 5690-5699, 2006
882006
Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19
AH Briggs, DA Goldstein, E Kirwin, R Meacock, A Pandya, DJ Vanness, ...
Health Economics 30 (3), 699-707, 2021
762021
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
LJ Mundal, J Igland, MB Veierød, KB Holven, L Ose, RM Selmer, T Wisloff, ...
Heart 104 (19), 1600-1607, 2018
702018
Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
M Korman, T Wisløff
European Heart Journal–Cardiovascular Pharmacotherapy 4 (1), 15-22, 2018
682018
More use of peritoneal dialysis gives significant savings: a systematic review and health economic decision model
E Pike, V Hamidi, T Ringerike, T Wisloff, M Klemp
Journal of clinical medicine research 9 (2), 104, 2017
662017
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation
T Wisløff, G Hagen, M Klemp
Pharmacoeconomics 32, 601-612, 2014
662014
Lung function increases with increasing level of physical activity in school children
S Berntsen, T Wisløff, P Nafstad, W Nystad
Pediatric exercise science 20 (4), 402-410, 2008
622008
Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report
OL Mandrik, JLH Severens, A Bardach, S Ghabri, C Hamel, T Mathes, ...
Value in Health 24 (4), 463-472, 2021
582021
Cognitive patient education for low back pain in primary care: a cluster randomized controlled trial and cost-effectiveness analysis
EL Werner, K Storheim, I Løchting, T Wisløff, M Grotle
Spine 41 (6), 455-462, 2016
572016
Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden
A Bergman, J Hjelmgren, Å Örtqvist, T Wisløff, I Sønbø Kristiansen, ...
Scandinavian journal of infectious diseases 40 (9), 721-729, 2008
422008
Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction
R Selmer, S Halvorsen, KI Myhre, TF Wisløff, IS Kristiansen
Scandinavian Cardiovascular Journal 39 (5), 276-285, 2005
412005
Long-term, self-reported health outcomes in kidney donors
K Meyer, AK Wahl, IT Bjørk, T Wisløff, A Hartmann, MH Andersen
BMC nephrology 17, 1-10, 2016
402016
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
SKH Bøhn, L Thorsen, CE Kiserud, SD Fosså, HC Lie, JH Loge, T Wisløff, ...
Acta Oncologica 58 (5), 753-762, 2019
392019
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease-A cost-effectiveness analysis
T Wisløff, RM Selmer, S Halvorsen, A Fretheim, OF Norheim, ...
BMC cardiovascular disorders 12, 1-12, 2012
392012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20